The goal of this clinical trial is to evaluate the diagnostic efficacy and safety of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology in peripheral lung lesions. The main question it aims to answer are: the effectiveness and safety of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.

Participants will undergo CT-guided percutaneous lung biopsy or percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.

Inclusion Criteria:

• Age 18-80 years old
• Imaging examination showed peripheral lung lesions
• Selected patients need to complete routine preoperative examinations such as blood routine examination, coagulation function, electrocardiogram, chest CT, etc
• There is no contraindication for puncture biopsy
• Good compliance, able to cooperate with research and observation
• Fully informed of the purpose and method of the study, agreed to participate in the study, and signed the informed consent form

Exclusion Criteria:

• Severe cardiopulmonary insufficiency, extreme weakness and intolerance of patients
• The patient is allergic to lidocaine and midazolam
• The site to be biopsied has a high risk of bleeding such as bronchial artery penetration or suspected lung metastasis of renal cancer
• Unstable angina pectoris, congestive heart failure, severe bronchial asthma
• The patient did not agree to participate in the study
• Participation in other studies within three months without withdrawal or termination will affect the observation of this study
• The researcher believes that there is any person who is not suitable for the selection